Stanford, CA, United States of America

Hannah Valantine

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 101(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: **Hannah Valantine: Pioneering Innovations in Microbiome Analysis and Organ Transplantation**

Introduction

Hannah Valantine, an esteemed inventor based in Stanford, California, has made significant contributions to the fields of microbiome analysis and organ transplantation. With a remarkable portfolio of 16 patents, her work focuses on developing methods and devices that enhance our understanding of the human microbiome and improve transplant outcomes.

Latest Patents

Two of her most recent patents highlight the innovative nature of her work. The first patent, titled "Cell-free nucleic acids for the analysis of the human microbiome and components thereof," provides advanced methods, devices, compositions, and kits aimed at analyzing the microbiome. These methods not only assist in determining infections but also analyze microbiome structures and assess an individual's immunocompetence. The invention includes potential therapeutic regimens such as drugs, diet, and radiation therapy tailored to enhance treatment effectiveness.

The second patent focuses on the "Non-invasive diagnosis of graft rejection in organ transplant patients." This invention provides comprehensive methods, devices, compositions, and kits designed to diagnose or predict the status and outcomes of transplant recipients, significantly improving patient care in the transplantation field.

Career Highlights

Hannah Valantine is affiliated with Leland Stanford Junior University, a prestigious institution recognized for its research excellence. Her career is marked by her dedication to advancing medical science through innovative approaches that address critical health issues.

Collaborations

Throughout her career, Valantine has collaborated with prominent figures in the scientific community, including Stephen R. Quake and Thomas M. Snyder. These collaborations have further enriched her research, allowing her to apply multidisciplinary insights into her work.

Conclusion

Hannah Valantine stands out as a leading inventor with a vision for transforming healthcare. Her impactful patents reflect a commitment to pioneering solutions that address complex medical challenges. As she continues to innovate, her contributions promise to enhance our understanding of the human microbiome and improve outcomes for organ transplant patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…